NPR reports that some people with diabetes have had to cut back on the ... a therapy plan that includes pharmaceutical products. GSK plc (NYSE:GSK) develops and markets a wide range of healthcare ...

GlaxoSmithKline's approval review date for its diabetes drug has been pushed back by three months by the US Food and Drug Administration (FDA). The US Prescription Drug User Fee Act goal date for ...

GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks Consensus Estimate of 53 cents. Core earnings declined 20% year over ...

The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut bacteria then convert it into chemicals that improve the insulin response.

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... According to JP Morgan Research, obesity and diabetes will drive the GLP-1 market’s growth to $100 billion by 2030.